APNA CLINICAL PSYCHOPHARMACOLOGY INSTITUTE PROGRAM

Advancing Integration of Pharmacology in Person Centered Nursing

Women collaborating at the Clinical Psychopharmacology Institute

Earn up to 22.5 contact hours in pharmacology Thursday - Sunday.

Thursday Pre-Conference*, June 6
2.0 Contact hours

 

4:00pm - 7:00pm

Registration Open


5:00pm - 7:00pm


PRE-CONFERENCE COURSE*:  Deep Dive into Neurotransmitters: Focus on Glutamate & GABA
Debbie Thomas, EdD, APRN, PMHCNS/NP-BC, CMP – Register for this pre-conference course to explore neurotransmitters, particularly glutamate and GABA, from a psychopharmacological perspective. You’ll also leave this course with a better understanding of how this neurobiology relates to the lived experience of persons with mental health disorders. *Thursday night Pre-Conference sessions are not included in the conference registration rate. To attend this session and earn 2.0 contact hours, select the pre-conference during registration. An additional cost will apply.

 
Friday, June 7
8 Contact Hours


7:30am


Registration Open


8:00am - 9:30am
1.5 Contact Hours


Remission Versus Recovery: An Opportunity to Engage People Living with Schizophrenia Earlier Using LAIs
Rebecca S. Roma MD, MBA

Examine the course of illness in clients with schizophrenia. Review recent research comparing oral medications and LAIs (long acting injectables). Discuss how we can involve clients earlier in the course of disease and engage them to consider long acting treatment options.


9:45am - 11:15am
1.5 Contact Hours


Complex Issues in Pediatric Psychopharmacology: Depressive & Anxiety Disorders
Jeffrey R. Strawn, MD, FAACAP

Focus on the first-line psychopharmacologic treatments for youth with DSM-5 depressive and anxiety disorders. Explore the comparative pharmacology of the SSRIs and SSNRIs-based on key pediatric trials-and review evidence supporting other psychopharmacologic interventions. Review differences in efficacy and tolerability of pharmacotherapy in youth and discuss strategies to identify which treatment may work best for which patient (e.g., predictors of treatment response).


11:30am - 1:00pm
 


Symposium Luncheon** Clinical Convergence®: Child and Adolescent Bipolar Depression
Lunch: 11:30am – 12:00pm  |  Presentation: 12:00pm – 1:30pm
Sara Jones, PhD, RN, APRN, PMHNP-BC, Robert A. Kowatch, MD, MBA
Contact hours for this symposium luncheon are not provided by APNA. 


1:45pm - 3:15pm
1.5 Contact Hours


Sexual Issues and Psychotropics – Identification and Treatment Strategies
Sattaria 'Tari' Dilks, DNP, APRN, PMHNP-BC, FAANP

Sexual side effects to psychotropic drugs is one of the reasons that many clients prematurely discontinue otherwise effective medication regimens to treat psychiatric disorders.  Some psychiatric patients have difficulty with sexuality as a result of the disorders they cope with, and adding on sexual side effects further isolates them in their recovery efforts. This presentation will discuss the pathways involved in disrupted sexual response, how psychotropics interact with those pathways and review potential treatment options that may be appropriate to combat these side effects.


3:30pm - 5:00pm
1.5 Contact Hours


Ethical Decision-Making in Mental Health & Psychopharmacology
Douglas P. Olsen, PhD, RN; Barbara Limandri, PhD, PMHCNS-BC; Barbara Jones Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN

Discuss ethical considerations in psychopharmacological clinical practice with three nursing experts. Use an ethical decision-making framework to help navigate ethical dilemmas encountered by psychiatric-mental health nurses in clinical practice.


5:00pm - 5:30pm
0.5 Contact Hours


Outcomes Panel
CPI Program Committee
 

Saturday, June 8
6.5 Contact Hours


7:30am


Registration Open


8:00am - 9:30am
1.5 Contact Hours


Managing Pharmacologic Treatments for Older Adults
Elizabeth Galik, PhD, CRNP, FAAN, FAANP

Focus on deprescribing benzodiazepines and antipsychotics when managing anxiety and agitation in older adults, explore alternative pharmacological options, and understand how to use these medications appropriately and safely when necessary.


9:45am - 11:15am
1.5 Contact Hours


Complex Topics in Substance Use – Drug Adulterants, Treatment Transitions, & Pregnancy
Matt Tierney, ANP, PMHNP, FAAN

Examine hot topics in substance use disorders to gain an understanding of current and emerging needs, including: adulterants in the illicit drug supply and related harm reduction strategies; transitions in medication treatment for opioid use; and treatment of opioid use disorder during pregnancy and post-partum period.


11:30am - 12:00pm


Networking Break


12:00pm - 1:30pm
 


Product Theater Lunch** Impact of Bipolar Disorder: The Need for Accurate Diagnosis and Effective Treatment
Sponsored by Sunovion Pharmaceuticals Inc.
Alice R. Mao, MD
No contact hours provided.


1:45pm - 3:15pm
1.5 Contact Hours


The Art of Deprescribing: An Evidence-Based Approach to Understanding Who is the Right Patient, When is it the Right Time, and How to Taper the Medication?
Dawn Vanderhoef, PhD, DNP, PMHNP-BC, FAANP

Get the current evidence-based practices for weaning patients off medications safely and effectively. Understand how these processes and considerations fit into the wellness approach you take in providing care.


3:30pm - 5:00pm
1.5 Contact Hours


Youth Suicide: The Public Health Challenge and Strategies for Prevention
John V. Campo, MD

Discuss the epidemiology of youth suicide and review existing evidence for indicated, selective, and universal strategies for prevention.


5:00pm - 5:30pm
0.5 Contact Hours

 


Outcomes Panel
CPI Program Committee

Sunday, June 9
6.0 Contact Hours

 

7:30am

Registration Open


8:00am - 9:30am
1.5 Contact Hours


From Immediate Release to Long Acting, Drug Delivery Systems: What Do They Mean & Why Do They Matter?
Laura G Leahy, DrNP, APRN, FAANP

Transform your clinical approach to the use of unique drug delivery systems to improve patient adherence, reduce poly pharmacy & minimize adverse events, while providing your patients with the medication management options that meet their individual needs. Exploring the neurobiology related to various psychotropic medications and their mechanism of action will enhance your understanding of why drug delivery systems matter.


9:45am - 11:15am
1.5 Contact Hours


Gabapentin Use & Misuse
Christian J. Teter, PharmD, BCPP

Take a look at the FDA indications and safe dosing for Gabapentin in psychiatry, then explore the slippery slope of off label use, dosing, and abuse. Understand the pharmacodynamic aspects of this drug which primed it for its current misuse on the street.


11:15am - 12:15pm


Brunch provided


12:15pm - 1:45pm
1.5 Contact Hours


Pharmacological Management of Alzheimer’s Disease and Other Neurocognitive Disorders
Pamela Z. Cacchione, PhD, CRNP, BC, FGSA, FAAN

Delve into key considerations for making pharmacologic decisions across the Alzheimer’s disease and other neurocognitive disorders. Use a holistic methodology to ensure patient-centered care that encompasses family and support factors.


2:00pm - 3:30pm
1.5 Contact Hours


Neurobiologic Aspects of Trauma
Elizabeth Fitelson, MD

Appreciate the how the phases of intimate partner violence and/or sexual assault impact prescribing practices. Link that knowledge to the neurobiological aspects of trauma and how medications address this population's needs on several levels.

 


Earn up to 22.5 total contact hours Thursday - Sunday. 

 

Program is subject to change.  Please continue to check this page for updates.
The content of this CNE activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.


*Pre-Conference Session: Select the pre-conference session add-on during registration (additional fee) to earn up to an additional 2 contact hrs. Available in additional to full or one day conference registrations

**Note About Sponsored Meal Sessions: This conference includes sessions sponsored by industries, including pharmaceutical companies (e.g., Product Theaters, Symposia). These sessions typically include a meal that is paid for by the program's sponsor(s). Before deciding to attend these sessions, it is important for you to determine whether you are subject to any restrictions on your ability to accept meals or other similar items from these kinds of entities. These limitations could include federal and state requirements (e.g., Vermont), applicable nursing professional ethical guidelines, or restrictions imposed by your employer. For more detailed information on any restrictions that may apply to you, we suggest you consult your legal advisor, state board of nursing or your employer.

AMERICAN PSYCHIATRIC NURSES ASSOCIATION and APNA-Logoare registered in the U.S. Patent and Trademark Office as trademarks of the American Psychiatric Nurses Association.
The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.